CD34 and acute myeloid leukemia: This model is one of the best characterized AML models, and one of the very few for which an immuno-phenotype characterizing a strongly LSC-enriched cell population (LSCe) has been described (Lin− Sca1− c-Kit+ CD34+ CD16/CD32hi [49,51]).